prohormone


Also found in: Dictionary, Medical, Wikipedia.

prohormone

[′prō‚hȯr‚mōn]
(biochemistry)
The precursor of a hormone.
References in periodicals archive ?
2) Nonstandard abbreviations: hs, high sensitivity; AMI, acute myocardial infarction; cTnT, cardiactroponinT; ACS, acute coronary syndrome; ED, emergency department; STEMI, ST segment elevation myocardial infarction; AUC, area under the curve; LBBB, left bundle branch block; UAP, unstable angina pectoris; GRACE, Global Registry of Acute Coronary Events; NT-proBNP, N-terminal of the prohormone brain natriuretic peptide; IQR, interquartile range; PCI, percutaneous coronary intervention; HR, hazard ratio.
5) Nonstandard abbreviations: cTnI, cardiac troponin I; URL, upper reference limit; MI, myocardial infarction; hs, high-sensitivity; FDA, US Food and Drug Administration; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; LVEF, left ventricular ejection fraction; eGFR, estimated glomerular filtration rate; LoD, limit of detection.
It is then cleaved again into the biologically active B-type natriuretic peptide (BNP) and the inactive amino-terminal fragment, N-terminal prohormone of BNP (NT-proBNP).
The concentration of the Nterminal prohormone of brain natriuretic peptide (NT-proBNP) [1] is often increased in patients with a reduced renal function.
N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) was also measured on the Elecsys 2010 (Roche) with a limit of detection of 5.
Copeptin, a glycoprotein from the C-terminal fragment of the arginine vasopressin prohormone, is cosecreted with arginine vasopressin from the neurohypophysis.
LOS ANGELES -- Diagnostic Products Corporation (NYSE:DP) announced today the release outside the US of its assay for N-terminal prohormone brain natriuretic peptide (NT-proBNP).
The prohormone 25(OH)D undergoes further hydroxylation by CYP27B1 and CYP24A1 in the kidney to form different dihydroxyvitamin D metabolites, 1[alpha],25[(OH).
Roche Diagnostics and Diagnostic Products Corporation (NYSE:DP) announced today that Diagnostic Products Corporation (DPC) has been granted a nonexclusive license under patent rights of Roche Diagnostics relating to the development, manufacture and marketing of immunoassays that detect a key marker of congestive heart failure (CHF), NT-proBNP (N-terminal prohormone brain natriuretic peptide).
Roche Diagnostics and Dade Behring announced today that Dade Behring has been granted a non-exclusive license under patent rights of Roche Diagnostics relating to the development, manufacture and marketing of immunoassays that detect a key marker of congestive heart failure (CHF), NT-proBNP (N-terminal prohormone brain natriuretic peptide).
Copeptin, the C-terminal part of the vasopressin prohormone, is secreted stoichiometrically with arginine-vasopressin from the neurohypophysis.